Yes. Both Nevolat and Saxenda contain liraglutide 3.0 mg, carry the same MHRA licence, and work through the same GLP-1 mechanism. Nevolat is a generic brand — often available at a lower price point — but there is no clinical difference between the two. The NHS routinely prescribes generics on this basis.

Yes — the clinical evidence for liraglutide 3.0 mg applies fully to Nevolat because it is the same molecule. In the SCALE programme, patients achieved up to 8.4% average body weight reduction over 56 weeks alongside a reduced-calorie diet and exercise. Some patients lost significantly more. Individual outcomes vary; your Bliss clinician will set realistic expectations at consultation.

Attach a new needle to the pen and prime it before first use. Dial to your prescribed dose, clean and pinch the injection site, insert the needle at 90 degrees, and hold the button for 6 seconds to deliver the full dose. Rotate injection sites (stomach, thigh, upper arm) with each injection. See the full pen guide above for step-by-step instructions.

Each Nevolat pen contains 18 mg of liraglutide. At the maintenance dose of 3.0 mg per day, each pen lasts approximately 6 days. At lower escalation doses it lasts considerably longer — at 0.6 mg/day, the pen provides 30 doses (30 days). See the pen guide above for a full dose-by-dose breakdown.

Nevolat is a prescription medicine and cannot be purchased without a clinical consultation. At Bliss, pricing is transparent — see our pricing section above for current costs at each dose tier. As a generic, Nevolat is often available at a lower price point than branded Saxenda.

Nevolat is a prescription-only medicine — it cannot be purchased without a clinical assessment and a valid prescription from a registered prescriber. At Bliss, you can complete an online eligibility assessment and, if appropriate, receive a clinician-issued prescription and delivery from our GPhC-registered pharmacy.